APAC (Asia Pacific) Industry Committee

APAC Industry Committee

Established in 2022 between ISCT Asia Regional Executive Committee and ISCT Industry Leadership to support the rapid growth of the CGT market in the Asia Pacific Region. 

Committee Charter

APAC IC addresses challenges and bottlenecks impacting CGT development unique to the region, while promoting communication and alignment between Eastern and Western perspectives.

Projects & Objectives

• Developing Regulatory Roadmap across 8 key APAC regions
• ISCT Workforce Development regional initiatives
• ISCT Annual Meeting Roundtable curation related to Global Market & Partnering Strategies
• MOU with FIRM & APACRM
  

APAC Industry Committee Roster

CO-CHAIR

William Hwang

MBBS, MMed, FRCP, FAMS National Cancer Center,
SingHealth, Singapore

CO-CHAIR

Antonio S. J. Lee, BSc.(Hons), MSc., Ph.D

Medipost Co., Ltd.
South Korea & USA

Members:

Nathan Dai, Cryoport, USA

Lisa Guan, Miltenyi Biotec

Pawan Gupta, Asia VP Elect, IND

Juliana Gutierrez, BioMérieux, JP

William YK Hwang, Asia VP, SG

Shin Kawamata, Asia Secretary, JP

Srinivasan Kellathur, Reg. Advisor, SG

Kilian Kelly, Cynata, ANZ

Wenyan Leong, Terumo BCT, JP

 Kang Liu, AGC Biologics, CH

 Bev Menner, Cell Therapies, AU

 Bill Milligan, Steminent CA/JP

 Takuya Muramoto, Minaris AT, JP

 John Ng, DHC, SG  

 Albeena Nisar, ESP, IND

Steve Oh, Independent, SG

Jungsoo Park,PL Bioscience GER

Sarah Phillips, Invetech, AU

Gabrielle O’Sullivan, Reg. Advisor, AU

Kunihiko Suzuki, Asia VP, JP

Eddie Tan ESP, SG

Yasuhiro Takagi, FIRM, JP

Chihiro Wakayama Mitsubishi JP

Zlatibor Velickovic, Ex Officio, AU 

Shane Winzar, Au Red Cross, AU

Bin Wu, Azenta, CH

Yu Yanagisawa, Cell Fiber, JP

Peiqing Zhang, Cytiva, SG